Drug Shortage Report for PROQUAD
| Report ID | 256949 |
| Drug Identification Number | 02399229 |
| Brand name | PROQUAD |
| Common or Proper name | measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RUBELLA VIRUS LIVE ATTENUATED MUMPS VIRUS LIVE ATTENUATED MEASLES VIRUS LIVE ATTENUATED VARICELLA VIRUS LIVE ATTENUATED |
| Strength(s) | 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50 3.99Log10 PFU |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 10 X 1 DOSE VIAL |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-11-28 |
| Actual start date | |
| Estimated end date | 2026-03-31 |
| Actual end date | 2025-11-11 |
| Shortage status | Avoided shortage |
| Updated date | 2025-11-11 |
| Company comments | Remaining doses are reserved for the public immunization program |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2025-11-11 | French | Compare |
| v13 | 2025-11-11 | English | Compare |
| v12 | 2025-10-22 | French | Compare |
| v11 | 2025-10-22 | English | Compare |
| v10 | 2025-08-25 | French | Compare |
| v9 | 2025-08-25 | English | Compare |
| v8 | 2025-07-25 | French | Compare |
| v7 | 2025-07-25 | English | Compare |
| v6 | 2025-06-26 | French | Compare |
| v5 | 2025-06-26 | English | Compare |
| v4 | 2025-05-29 | French | Compare |
| v3 | 2025-05-29 | English | Compare |
| v2 | 2025-05-09 | French | Compare |
| v1 | 2025-05-09 | English | Compare |
Showing 1 to 14 of 14